{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:51:29Z","timestamp":1787899889533,"version":"build-2784847793"},"reference-count":125,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The WHO recently endorsed an ambitious plan, \u201cDefeating Meningitis by 2030\u201d, that aims to control\/eradicate invasive bacterial infection epidemics by 2030. Vaccination is one of the pillars of this road map, with the goal to reduce the number of cases and deaths due to Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus agalactiae. The risk of developing invasive bacterial infections (IBI) due to these bacterial species includes genetic and acquired factors that favor repeated and\/or severe invasive infections. We searched the PubMed database to identify host risk factors that increase the susceptibility to these bacterial species. Here, we describe a number of inherited and acquired risk factors associated with increased susceptibility to invasive bacterial infections. The burden of these factors is expected to increase due to the anticipated decrease in cases in the general population upon the implementation of vaccination strategies. Therefore, detection and exploration of these patients are important as vaccination may differ among subjects with these risk factors and specific strategies for vaccination are required. The aim of this narrative review is to provide information about these factors as well as their impact on vaccination against the four bacterial species. Awareness of risk factors for IBI may facilitate early recognition and treatment of the disease. Preventive measures including vaccination, when available, in individuals with increased risk for IBI may prevent and reduce the number of cases.<\/jats:p>","DOI":"10.3390\/microorganisms9030467","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:36:13Z","timestamp":1614220573000},"page":"467","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-1732","authenticated-orcid":false,"given":"Ala-Eddine","family":"Deghmane","sequence":"first","affiliation":[{"name":"Invasive Bacterial Infections Unit, Institut Pasteur, 28 Rue du Dr. Roux, CEDEX 15, 75724 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"Invasive Bacterial Infections Unit, Institut Pasteur, 28 Rue du Dr. Roux, CEDEX 15, 75724 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2018, January 18\u201319). Defeating meningitis by 2030. Proceedings of the First Meeting of the Technical Taskforce, World Health Organization, Geneva, Switzerland. WHO: 2019."},{"key":"ref_2","first-page":"126","article-title":"Insights into the population structure and pan-genome of Haemophilus influenzae","volume":"67","author":"Pinto","year":"2019","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S0950268803008847","article-title":"Molecular epidemiology of group B streptococci in Ireland: Associations between serotype, invasive status and presence of genes encoding putative virulence factors","volume":"131","author":"Dore","year":"2003","journal-title":"Epidemiol. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Spindler","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1469-0691.2008.01955.x","article-title":"Hyperinvasive genotypes of Neisseria meningitidis in France","volume":"14","author":"Zarantonelli","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of Serogroups and Genotypes among Disease-Associated and Carried Isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.7.1.1","article-title":"A study of the virulence of meningococci for man and of human susceptibility to meningococcic infection","volume":"7","author":"Heist","year":"1922","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","article-title":"Complement in immune and inflammatory disorders: Therapeutic interventions","volume":"190","author":"Ricklin","year":"2013","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"Lewis","year":"2014","journal-title":"Virulence"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: Lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1182\/blood-2005-07-2820","article-title":"Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections","volume":"107","author":"Sprong","year":"2006","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2019.01936","article-title":"Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies","volume":"10","author":"Rosain","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jix143","article-title":"Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies","volume":"215","author":"Rosain","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ladhani, S.N., Campbell, H., Lucidarme, J., Gray, S., Parikh, S., Willerton, L., Clark, S.A., Lekshmi, A., Walker, A., and Patel, S. (2019). Invasive meningococcal disease in patients with complement deficiencies: A case series (2008\u20132017). BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4146-5"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/inf.1983.15.issue-4.04","article-title":"Fulminant meningococcal infections in a family with inherited deficiency of properdin","volume":"15","author":"Braconier","year":"1983","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_22","first-page":"291","article-title":"Properdin deficiency in a family with fulminant meningococcal infections","volume":"50","author":"Sjoholm","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1080\/08035250600603008","article-title":"Properdin deficiency in a boy with fulminant meningococcal septic shock","volume":"95","author":"Genel","year":"2006","journal-title":"Acta Paediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/00365548909035695","article-title":"Another Swedish family with complete properdin deficiency: Association with fulminant meningococcal disease in one male family member","volume":"21","author":"Soderstrom","year":"1989","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00041552-199905000-00005","article-title":"Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis","volume":"8","author":"Berden","year":"1999","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fimmu.2019.01157","article-title":"Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT","volume":"10","author":"Risitano","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3389\/fimmu.2019.01007","article-title":"The Challenges and Promise of Complement Therapeutics for Ocular Diseases","volume":"10","author":"Park","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","article-title":"Developments in anti-complement therapy; from disease to clinical trial","volume":"102","author":"Harris","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2019040331","article-title":"Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome","volume":"30","author":"Zuber","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement Activation in Patients with Covid-19: A Novel Therapeutic Target","volume":"146","author":"Cugno","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"ref_34","first-page":"1","article-title":"Risk factors for invasive meningococcal disease: A retrospective analysis of the French national public health insurance database","volume":"17","author":"Taha","year":"2021","journal-title":"Hum. Vacc. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/bmt.2016.181","article-title":"Bacterial meningitis in hematopoietic stem cell transplant recipients: A population-based prospective study","volume":"51","author":"Brouwer","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/tid.12570","article-title":"Bacterial meningitis in solid organ transplant recipients: A population-based prospective study","volume":"18","author":"Brouwer","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/INF.0b013e3181d3ce32","article-title":"Groupe des pediatres et microbiologistes de l\u2019Observatoire National des M: Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children","volume":"29","author":"Levy","year":"2010","journal-title":"Pediatric Infect. Dis. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM200108093450603","article-title":"Dysfunction of endothelial protein C activation in severe meningococcal sepsis","volume":"345","author":"Faust","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(99)02220-5","article-title":"4G\/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group","volume":"354","author":"Hermans","year":"1999","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(13)60315-3","article-title":"Pachymeningitis after meningococcal infection","volume":"381","author":"Toubiana","year":"2013","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","first-page":"251","article-title":"Management of infection risk in asplenic patients","volume":"32","author":"Debaene","year":"2013","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","article-title":"Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals","volume":"72","author":"Balmer","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbmt.2011.07.027","article-title":"Safety and Immunogenicity of the Tetravalent Protein-Conjugated Meningococcal Vaccine (MCV4) in Recipients of Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation","volume":"18","author":"Mahler","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_45","unstructured":"Centers for Disease Control and Prevention (CDC) (2011). Updated recommendations for use of meningococcal conjugate vaccines---Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly. Rep., 60, 72\u201376."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1744-313X.2006.00613.x","article-title":"The FCGR2A--Arg131 variant is no major mortality factor in the elderly--evidence from a German centenarian study","volume":"33","author":"Flesch","year":"2006","journal-title":"Int. J. Immunogenet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/656236","article-title":"Association between single-nucleotide polymorphisms in Mal\/TIRAP and interleukin-10 genes and susceptibility to invasive Haemophilus influenzae serotype b infection in immunized children","volume":"51","author":"Ladhani","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1001\/jama.1992.03490230080032","article-title":"Invasive Haemophilus influenzae infections in men with HIV infection","volume":"268","author":"Steinhart","year":"1992","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/sim.1417","article-title":"Implications of genetic traits on vaccine efficacy","volume":"22","author":"Murthy","year":"2003","journal-title":"Stat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Brown, A.O., Mann, B., Gao, G., Hankins, J.S., Humann, J., Giardina, J., Faverio, P., Restrepo, M.I., Halade, G.V., and Mortensen, E.M. (2014). Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004383"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/joim.12875","article-title":"Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia","volume":"285","author":"Feldman","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100.e1","DOI":"10.1016\/j.amjmed.2017.06.039","article-title":"Effect of Age on the Manifestations and Outcomes of Invasive Pneumococcal Disease in Adults","volume":"131","author":"Marrie","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"Brouwer","year":"2016","journal-title":"Nat. Rev. Dis Primers"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: Epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0029-1202939","article-title":"Streptococcus pneumoniae: Does antimicrobial resistance matter?","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: A prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.vaccine.2017.05.049","article-title":"Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study","volume":"35","author":"LeBlanc","year":"2017","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2012.04.006","article-title":"Network ISGI: Invasive pneumococcal disease associated with high case fatality in India","volume":"66","author":"Thomas","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(08)70261-5","article-title":"Host genetic susceptibility to pneumococcal and meningococcal disease: A systematic review and meta-analysis","volume":"9","author":"Brouwer","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_60","first-page":"53","article-title":"Risk factors for community-acquired bacterial meningitis in adults","volume":"73","author":"Adriani","year":"2015","journal-title":"Neth. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccm.2004.10.002","article-title":"Genetic susceptibility to pneumonia","volume":"26","author":"Waterer","year":"2005","journal-title":"Clin. Chest Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamapediatrics.2019.3203","article-title":"Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era: A Systematic Review","volume":"173","author":"Butters","year":"2019","journal-title":"JAMA Pediatr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00130832-200312000-00006","article-title":"Primary immunodeficiencies associated with pneumococcal disease","volume":"3","author":"Picard","year":"2003","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: Report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198511143132002","article-title":"Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency","volume":"313","author":"Umetsu","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2249.1993.tb03353.x","article-title":"Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults","volume":"91","author":"Lortan","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: Clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/00365549509018989","article-title":"Complement analysis in adult patients with a history of bacteremic pneumococcal infections or recurrent pneumonia","volume":"27","author":"Ekdahl","year":"1995","journal-title":"Scand. J. Infect. Dis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/infdis\/142.6.903","article-title":"The critical role of complement in experimental pneumococcal sepsis","volume":"142","author":"Hosea","year":"1980","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(02)08516-1","article-title":"MBL genotype and risk of invasive pneumococcal disease: A case-control study","volume":"359","author":"Roy","year":"2002","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.humimm.2006.04.014","article-title":"Mannose-binding lectin genotype and invasive pneumococcal infection","volume":"67","author":"Moens","year":"2006","journal-title":"Hum. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/340216","article-title":"Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients","volume":"185","author":"Kronborg","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/590006","article-title":"Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection","volume":"47","author":"Eisen","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"Picard","year":"2008","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpeds.2004.06.065","article-title":"Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4","volume":"145","author":"Enders","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0105-2896.2005.00235.x","article-title":"Inherited disorders of human Toll-like receptor signaling: Immunological implications","volume":"203","author":"Ku","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20070628","article-title":"Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity","volume":"204","author":"Ku","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jmg.2006.044446","article-title":"IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease","volume":"44","author":"Ku","year":"2007","journal-title":"J. Med. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.all.0000191241.66373.74","article-title":"The range of defects associated with nuclear factor kappaB essential modulator","volume":"5","author":"Uzel","year":"2005","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","article-title":"Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia","volume":"2","author":"Jain","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/316914","article-title":"A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)","volume":"67","author":"Zonana","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","article-title":"Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother","volume":"109","author":"Corradini","year":"2002","journal-title":"Pediatrics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1086\/431994","article-title":"Septicemia without sepsis: Inherited disorders of nuclear factor-kappa B-mediated inflammation","volume":"41","author":"Puel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.20030701","article-title":"Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections","volume":"198","author":"Medvedev","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bjs.1800780904","article-title":"Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks","volume":"78","author":"Holdsworth","year":"1991","journal-title":"Br. J. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/516781","article-title":"Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine","volume":"44","author":"Halasa","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1542\/peds.2006-3268","article-title":"Trends in hospitalizations of HIV-infected children and adolescents in the United States: Analysis of data from the 1994-2003 Nationwide Inpatient Sample","volume":"120","author":"Kourtis","year":"2007","journal-title":"Pediatrics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/adc.88.12.1112","article-title":"The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi","volume":"88","author":"Molyneux","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"ref_95","first-page":"1","article-title":"Human B and T lymphocyte responses to vaccination with pneumococcal polysaccharides","volume":"15","author":"Heilmann","year":"1990","journal-title":"APMIS Suppl."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/505309","article-title":"Respiratory viruses in children with invasive pneumococcal disease","volume":"43","author":"Peltola","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1086\/313772","article-title":"Severe pneumococcal pneumonia in previously healthy children: The role of preceding influenza infection","volume":"30","author":"Walters","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/529438","article-title":"Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged < 2 years: A population-based cohort study","volume":"46","author":"Stensballe","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"Active Bacterial Core Surveillance Program of the Emerging Infections Program N: The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.md.0000180045.26909.29","article-title":"Streptococcus pneumoniae bacteremia in patients with cancer: Disease characteristics and outcomes in the era of escalating drug resistance (1998\u20132002)","volume":"84","author":"Kumashi","year":"2005","journal-title":"Medicine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Medical Advisory Committee of the Immune Deficiency Foundation, Shearer, W.T., Fleisher, T.A., Buckley, R.H., Ballas, Z., Ballow, M., Blaese, R.M., Bonilla, F.A., Conley, M.E., and Cunningham-Rundles, C. (2014). Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J. Allergy Clin. Immunol., 133, 961\u2013966.","DOI":"10.1016\/j.jaci.2013.11.043"},{"key":"ref_104","unstructured":"(HCSP) HCdlSP (2014). Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques. Recommandations actualis\u00e9es. Collections et Avis, Haut Conseil de la Sant\u00e9 Publique (HCSP)."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(96)70365-7","article-title":"Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease","volume":"128","author":"Steele","year":"1996","journal-title":"J. Pediatr."},{"key":"ref_106","first-page":"33N","article-title":"Infection associated with asplenia: Risks, mechanisms, and prevention","volume":"88","author":"Styrt","year":"1990","journal-title":"Am. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jcp.54.3.214","article-title":"Overwhelming infection in asplenic patients: Current best practice preventive measures are not being followed","volume":"54","author":"Waghorn","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jaci.2008.08.012","article-title":"Immunoglobulin therapy: Methods of delivery","volume":"122","author":"Ballow","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(18)30555-3","article-title":"Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014-15: A prospective surveillance study","volume":"19","author":"Lamagni","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s15010-007-7251-0","article-title":"Invasive group B Streptococcal disease in non-pregnant adults: A review with emphasis on skin and soft-tissue infections","volume":"36","author":"Sendi","year":"2008","journal-title":"Infection"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/599369","article-title":"Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990\u20132007","volume":"49","author":"Skoff","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1017\/S0950268815000606","article-title":"Group B streptococcus infections of soft tissue and bone in California adults, 1995\u20132012","volume":"143","author":"Smith","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency","volume":"89","author":"Picard","year":"2010","journal-title":"Medicine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mib.2011.12.002","article-title":"Group B Streptococcus surface proteins as major determinants for meningeal tropism","volume":"15","author":"Tazi","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1086\/630206","article-title":"Very late-onset group B Streptococcus meningitis, sepsis, and systemic shigellosis due to interleukin-1 receptor-associated kinase-4 deficiency","volume":"49","author":"Krause","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00001-11","article-title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency","volume":"24","author":"Picard","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review","volume":"65","author":"Turner","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: A randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/14760584.2018.1496021","article-title":"Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines","volume":"17","author":"Dzanibe","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/cid\/ciy838","article-title":"A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III","volume":"68","author":"Hillier","year":"2019","journal-title":"Clin. Infect. Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/3\/467\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:58Z","timestamp":1760160478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/3\/467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":125,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["microorganisms9030467"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms9030467","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}